How AI Is Reshaping Rare Disease Research
From genomic analysis to matching drugs with diseases, AI is giving small research teams new leverage. A practical look at what it can and cannot do.
Canada’s National Strategy for Rare Disease Drugs: What It Means for Patients and Researchers
Canada has committed federal funding to improve access to drugs for rare diseases. A plain-language look at the strategy and the opportunities it creates.
The Diagnostic Odyssey: Why Rare Disease Patients Wait Years for Answers
Many people with a rare disease see multiple specialists before getting a diagnosis. We look at why it happens and what is helping shorten the journey.
Drug Repurposing: Finding New Uses for Medicines We Already Have
Repurposing approved drugs for rare diseases can be faster and cheaper than developing a new compound from scratch. Here is how it works and where AI fits in.
What Counts as a Rare Disease? Why 1 in 12 Canadians Is Not So Rare
A rare disease affects few people individually, but together they touch millions of Canadians. Here is what the definition means and why it matters for research.